<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg (Tehran)</journal-id><journal-id journal-id-type="iso-abbrev">Emerg (Tehran)</journal-id><journal-id journal-id-type="publisher-id">Emerg</journal-id><journal-title-group><journal-title>Emergency</journal-title></journal-title-group><issn pub-type="ppub">2345-4563</issn><issn pub-type="epub">2345-4571</issn><publisher><publisher-name>Shahid Beheshti University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29201963</article-id><article-id pub-id-type="pmc">5703758</article-id><article-id pub-id-type="doi">10.22037/emergency.v5i1.18805</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Valsalva maneuver using a Handmade Device in Supraventricular Tachycardia Reversion; a Quasi Experimental Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Motamedi</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Akbarzadeh</surname><given-names>Mohammad Ali</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Safari</surname><given-names>Saeed</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shahhoseini</surname><given-names>Mehrnoosh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Emergency Department, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</aff><aff id="aff2">
<label>2</label>Cardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author: Mehrnoosh Shahhoseini; Emergency Department, Shohadaye Tajrish Hospital, Shardari Street, Tajrish Square, Tehran, Iran. Email: me.shahhoseini@gmail.com, Tel: 00989123072482</corresp></author-notes><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="epub"><day>15</day><month>10</month><year>2017</year></pub-date><volume>5</volume><issue>1</issue><elocation-id>e81</elocation-id><history><date date-type="received"><month>9</month><year>2017</year></date><date date-type="accepted"><month>10</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; Copyright (2017) Shahid Beheshti University of Medical Sciences</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Introduction:</title><p>The use of vagal nerve stimulation is identified as a proper treatment option in patients with stable supraventricular tachycardia (SVT). This study aimed to assess the success of Valsalva maneuver via a handmade device in reversion of SVT.</p></sec><sec><title>Methods:</title><p> In this quasi experimental study, using a handmade device, vagus nerve stimulation was performed for SVT patients presenting to emergency department or cardiac intervention unit and the success rate and its related factors were assessed.</p></sec><sec><title>Results:</title><p>100 patients with the mean age of 53.05 &#x000b1; 13.70 years were studied (67% female). 12 (12%) cases were unable to do the maneuver. Out of the 88 (88.0%) patients who could perform the maneuver, 75 (85.2%) cases were unsuccessful. Dysrhythmia was controlled in 6 (6.8%) cases on the first attempt and in 7 (8.0%) cases on the second one (14.8% total success rate). 12 of the 13 cases (92.3%) with successful maneuver had history of SVT (p = 0.031). There was not any significant association between success rate and sex (p = 0.084), age (p = 0.744), or other medical histories (p &#x02265; 0.05). </p></sec><sec><title>Conclusion:</title><p>Based on the results of the present study, the success rate of Valsalva maneuver with the mentioned handmade device was calculated to be 14.8%. The only independent related factor of successful reversion was SVT history. </p></sec></abstract><kwd-group><title>Key Words</title><kwd>Vagus nerve stimulation</kwd><kwd>Valsalva maneuver</kwd><kwd>tachycardia</kwd><kwd>supraventricularm arrhythmias</kwd><kwd>cardiac</kwd><kwd>emergency service</kwd><kwd>hospital</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Supraventricular tachycardia (SVT) comprises a common group of cardiac arrhythmia in patients referring to emergency departments. The overall incidence of this acute phenomenon has been estimated to be 35 cases per 100,000 patients (<xref rid="B1" ref-type="bibr">1</xref>). SVT symptoms are often non-specific, which include chest pain, shortness of breath, sense of palpitation, pounding in the neck, and even some degree of psychological disturbances such as anxiety (<xref rid="B2" ref-type="bibr">2</xref>). Impulse formation and impulse conduction processes may both be disturbed (<xref rid="B3" ref-type="bibr">3</xref>). In fact, three mechanisms of triggered activity, reentry, or increased automaticity with atrioventricular node source or above cardiac tissue source may be involved in SVT (<xref rid="B4" ref-type="bibr">4</xref>). Hence, the initial management of SVT involves slow atrioventricular node conduction by evolving pharmacological approaches, mechanical maneuvers, or invasive approaches if required (<xref rid="B5" ref-type="bibr">5</xref>-<xref rid="B14" ref-type="bibr">14</xref>). </p><p>The use of vagal maneuvers is now identified as a proper treatment option for patients with stable SVT but its success rate varies between 6% and 54% (<xref rid="B15" ref-type="bibr">15</xref>-<xref rid="B19" ref-type="bibr">19</xref>). There are different options for performing vagal maneuvers including the Valsalva maneuver and carotid sinus massage (<xref rid="B20" ref-type="bibr">20</xref>). However, there is no measurable and controlled method in this regard. The present study aimed to assess the success of Valsalva maneuver via a handmade device in reversion of SVT.</p></sec><sec sec-type="methods"><title>Methods</title><p>
<bold><italic>Study design and setting</italic></bold>
</p><p>This quasi experimental multicenter study was performed from Oct 2014 to Oct 2016 at four general educational hospitals (Imam Hossein, Shohadaye Tajrish, Loghman Hakim, and Modarres Hospitals), Tehran, Iran. Using a handmade device, vagus stimulation was performed for patients presenting to emergency department or cardiac intervention unit following SVT. The study protocol was approved by ethics committee of Shahid Beheshti University of Medical Sciences. All researchers adhered to principles of Helsinki declaration and confidentiality of patients&#x02019; information.</p><p>Participants</p><p>The study was conducted on patients &#x0003e;18 years old who consecutively presented to emergency departments of the mentioned hospitals with the initial evidence of SVT (n = 45) or were scheduled for inducing arrhythmia by a cardiologist at cardiac intervention unit (n = 55). </p><p>Patients who were not able to perform the maneuver or did not give consent, those with hemodynamic instability, atrial fibrillation or flutter, malignant hypertension, or other contraindications for performing Valsalva maneuver (such as cerebral AVM, increased intraocular pressure, glaucoma, or third trimester of pregnancy) were excluded. </p><p>
<bold><italic>Procedure</italic></bold>
</p><p>For creating the Valsalva maneuver&#x02019;s handmade device, the cuff of the sphygmomanometer was disconnected and the device&#x02019;s pressure monitor was connected to a 90cm oxygen connector, and the end of connector was connected to a 10cc syringe (<xref ref-type="fig" rid="F1">figure 1</xref>).</p><p>Maneuver was performed in supine position and with 30 to 50 mmHg pressure for 15 seconds. If the first attempt was unsuccessful, another attempt was made after five minutes. In cases of unsuccessful reversion with two Valsalva maneuvers, pharmacological approach was begun. </p><p>During the maneuver performance, all required supportive instruments including intubation and defibrillation sets were available and the patients were under continuous cardiac and blood pressure monitoring. </p><p>
<bold><italic>Outcome</italic></bold>
</p><p>Achieving sinus rhythm following the first or second maneuver attempt was considered as the main outcome of study (successful maneuver). </p><p>
<bold><italic>Statistics analysis</italic></bold>
</p><p>Results were presented as mean &#x000b1; standard deviation (SD) or frequencies and percentages. Chi-square or Fisher's exact tests and t test were used for comparisons. Data were analyzed using SPSS 21 statistical software. P values of 0.05 or less were considered statistically significant. </p></sec><sec sec-type="results"><title>Results</title><p>
<bold><italic>Baseline characteristics</italic></bold>
</p><p>100 patients with the mean age of 53.05 &#x000b1; 13.70 years (22 - 85) were studied (67% female). The baseline characteristics of the subjects are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. Most patients were in the age range of 40 &#x02013; 60 years and 67% of them had history of SVT.</p><p>SVT had resulted from atrio-ventricular nodal re-entrant tachycardia (AVNRT) in 59%, atrio-ventricular reentrant tachycardia (AVRT) in 14%, and unknown origin in 27%. </p><p>
<bold><italic>Maneuver Outcome</italic></bold>
</p><p>12 (12%) cases were unable to do the maneuver. Out of the 88 (88.0%) patients who could perform the maneuver, 75 (85.2%) cases were unsuccessful. Dysrhythmia was controlled in 6 (6.8%) cases at the first attempt and in 7 (8.0%) cases at the second one (14.8% total success rate). </p><p>12 of the 13 cases (92.3%) of successful maneuver had history of SVT (p = 0.031). There was not any significant association between success rate and sex (p = 0.084), age (p = 0.744), or other medical histories (p &#x02265; 0.05). </p><p>Unable and unsuccessful cases were treated with ablation (52.9%), adenosine (40.4%), amiodarone (4.5%), and verapamil (2.2%). </p></sec><sec sec-type="discussion"><title>Discussion</title><p>Based on the results of the present study, the success rate of Valsalva maneuver with the introduced handmade device was estimated to be 14.8%. The only independent related factor of successful reversion was SVT history.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the studied patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" rowspan="1" colspan="1">
<bold>Variables</bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>Values</bold>
</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Female</td><td align="justify" rowspan="1" colspan="1">67 (67)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Male</td><td align="justify" rowspan="1" colspan="1">33 (33)</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Age (year)</bold>
</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">20 &#x02013; 40 </td><td align="justify" rowspan="1" colspan="1">16 (16)</td></tr><tr><td align="justify" rowspan="1" colspan="1">40 &#x02013; 60 </td><td align="justify" rowspan="1" colspan="1">50 (50)</td></tr><tr><td align="justify" rowspan="1" colspan="1">&#x02265; 60</td><td align="justify" rowspan="1" colspan="1">34 (34)</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Medical history</bold>
</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">Hypertension</td><td align="justify" rowspan="1" colspan="1">17 (17)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Diabetes mellitus</td><td align="justify" rowspan="1" colspan="1">19 (19)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Smoking</td><td align="justify" rowspan="1" colspan="1">10 (10)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Ischemic heart disease</td><td align="justify" rowspan="1" colspan="1">17 (17)</td></tr><tr><td align="justify" rowspan="1" colspan="1">SVT</td><td align="justify" rowspan="1" colspan="1">67 (67)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Arrhythmias </td><td align="justify" rowspan="1" colspan="1">6 (6)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Calcium blocker use</td><td align="justify" rowspan="1" colspan="1">11 (11)</td></tr><tr><td align="justify" rowspan="1" colspan="1">Beta blocker use</td><td align="justify" rowspan="1" colspan="1">45 (45)</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Weight (kg)</bold>
</td><td align="justify" rowspan="1" colspan="1">73.8 &#x000b1; 13.8</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Height (cm)</bold>
</td><td align="justify" rowspan="1" colspan="1">165.0 &#x000b1; 8.2</td></tr><tr><td align="justify" rowspan="1" colspan="1">
<bold>Heart rate (beats/minute)</bold>
</td><td align="justify" rowspan="1" colspan="1">173.3 &#x000b1; 25.7</td></tr></tbody></table><table-wrap-foot><p>
<italic>Data were presented as mean &#x000b1; standard deviation or number (%). </italic>
</p><p>
<italic>SVT: Supraventricular tachycardia.</italic>
</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>The handmade device used in the present study.</p></caption><graphic xlink:href="emerg-5-e81-g001"/></fig><p>Along with medications and ablation, the use of vagal maneuvers has been introduced as an alternative modality leading to reversion of AVRT and AVNRT in up to 54% of affected patients (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B21" ref-type="bibr">21</xref>). </p><p>Vagal maneuver can be the most successful method to reverse arrhythmias if the maneuver is performed in supine position with adequate intra-thoracic pressure (at least 30 mmHg) for at least 15 seconds (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Despite considering all the mentioned conditions, the success rate of this maneuver has been considerably low in almost all studies. As shown in our study, the vagal maneuver was successful only in 14.8% of subjects. This rate was about 19.4% in the report by Lim et al. (<xref rid="B17" ref-type="bibr">17</xref>). However, in animal and laboratory-based studies as well as in the new modified version of Valsalva maneuver, the rate of reversion was shown to be in the range of 45.9% to 54.3% (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B21" ref-type="bibr">21</xref>). </p><p>Taylor et al. showed that only few number of physicians give enough instructions to their patients regarding the position, duration, pressure and other characteristics of maneuver (<xref rid="B24" ref-type="bibr">24</xref>). </p><p>According to the second finding of our study, with respect to main determinants of the success of Valsalva maneuver to reverse SVT, none of the baseline characteristics, except for previous experiment of SVT, could predict high success rate for this maneuver. </p><p>Higher success of this maneuver to terminate SVT in those with previous SVT might be due to more careful and cautious performance of the maneuver by the specialists in this high risk group or more excitability of cardiac conductive system of those cases by inducing maneuver. </p><p>It seems that, a majority of patients who suffer from SVT may not benefit from Valsalva maneuver and thus, employing the modified maneuver is more recommended. Higher success of this maneuver in patients with history of SVT requires more evaluation. Therefore, further studies with larger and heterogonous samples and proper follow up are recommended.</p><p>
<bold><italic>Limitation</italic></bold>
</p><p>In this study, more than half of the participants were patients with induced arrhythmia by cardiologist, which may affect the response to treatment. </p></sec></body><back><ack><title>Acknowledgment</title><p>This article is derived from Dr. Mehrnoosh Shahhoseini&#x02019;s thesis for achieving a specialist degree in the field of emergency medicine at Shahid Beheshti University of medical sciences.</p></ack><sec><title>Conclusion</title><p>Based on the results of the present study, the success rate of Valsalva maneuver with the mentioned handmade device was calculated to be 14.8%. The only independent related factor of successful reversion was SVT history. </p></sec><sec><title>Author contribution</title><p>All authors passed four criteria for authorship contribution based on recommendations of the International Committee of Medical Journal Editors.</p></sec><sec><title>Funding/support</title><p>None</p></sec><sec><title>Conflict of interest</title><p>None</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orejarena</surname><given-names>LA</given-names></name><name><surname>Vidaillet</surname><given-names>H</given-names></name><name><surname>DeStefano</surname><given-names>F</given-names></name><name><surname>Nordstrom</surname><given-names>DL</given-names></name><name><surname>Vierkant</surname><given-names>RA</given-names></name><name><surname>Smith</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Paroxysmal supraventricular tachycardia in the general population</article-title><source> Journal of the American College of Cardiology</source><year>1998</year><volume>31</volume><issue>1</issue><fpage>150</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9426034</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bibas</surname><given-names>L</given-names></name><name><surname>Levi</surname><given-names>M</given-names></name><name><surname>Essebag</surname><given-names>V</given-names></name></person-group><article-title>Diagnosis and management of supraventricular tachycardias</article-title><source> CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne</source><year>2016</year><volume>188</volume><issue>17-18</issue><fpage>E466</fpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Zaiti</surname><given-names>SS</given-names></name><name><surname>Magdic</surname><given-names>KS</given-names></name></person-group><article-title>Paroxysmal Supraventricular Tachycardia</article-title><source> Critical Care Nursing Clinics</source><year>2016</year><volume>28</volume><issue>3</issue><fpage>309</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">27484659</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rujic</surname><given-names>D</given-names></name><name><surname>Sundb&#x000f8;ll</surname><given-names>J</given-names></name><name><surname>Tofig</surname><given-names>B</given-names></name><name><surname>Nielsen</surname><given-names>J</given-names></name><name><surname>Pareek</surname><given-names>M</given-names></name></person-group><article-title>Initial evaluation and management of paroxysmal supraventricular tachycardia</article-title><source> Ugeskrift for laeger</source><year>2016</year><volume>178</volume><issue>3</issue></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawan</surname><given-names>N</given-names></name><name><surname>Eitel</surname><given-names>C</given-names></name><name><surname>Thiele</surname><given-names>H</given-names></name></person-group><article-title>Ablation supraventrikul&#x000e4;rer Tachykardien</article-title><source> Herzschrittmachertherapie+ Elektrophysiologie</source><year>2016</year><volume>27</volume><issue>2</issue><fpage>143</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">27206630</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>RL</given-names></name><name><surname>Joglar</surname><given-names>JA</given-names></name><name><surname>Caldwell</surname><given-names>MA</given-names></name><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Conti</surname><given-names>JB</given-names></name><name><surname>Deal</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia</article-title><source> Journal of the American College of Cardiology</source><year>2016</year><volume>67</volume><issue>13</issue><fpage>e27</fpage><lpage>e115</lpage><pub-id pub-id-type="pmid">26409259</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>HM</given-names></name><name><surname>Sung</surname><given-names>RJ</given-names></name></person-group><article-title>Supraventricular tachyarrhythmias: Pharrnacologic versus nonpharrnacologic approaches</article-title><source> Medical Clinics of North America</source><year>1995</year><volume>79</volume><issue>5</issue><fpage>1121</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">7674687</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheinman</surname><given-names>M</given-names></name></person-group><article-title>Supraventricular tachyarrhythmias: drug therapy versus catheter ablation</article-title><source> Clinical cardiology</source><year>1994</year><volume>17</volume><issue>S2</issue></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldo</surname><given-names>AL</given-names></name></person-group><article-title>An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy</article-title><source> Clinical cardiology</source><year>1994</year><volume>17</volume><issue>S2</issue></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Sanders</surname><given-names>G</given-names></name><name><surname>Hlatky</surname><given-names>M</given-names></name><name><surname>Heidenreich</surname><given-names>P</given-names></name><name><surname>McDonald</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cost-Effectiveness of Radiofrequency Ablation for Supraventricular</article-title><source> Tachycardia</source><fpage>2000</fpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Link</surname><given-names>MS</given-names></name></person-group><article-title>Evaluation and initial treatment of supraventricular tachycardia</article-title><source> New England Journal of Medicine</source><year>2012</year><volume>367</volume><issue>15</issue><fpage>1438</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">23050527</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holdgate</surname><given-names>A</given-names></name><name><surname>Foo</surname><given-names>A</given-names></name></person-group><article-title>Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults</article-title><source> Cochrane Database Syst Rev</source><year>2006</year><fpage>4</fpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaney</surname><given-names>B</given-names></name><name><surname>Loy</surname><given-names>J</given-names></name><name><surname>Kelly</surname><given-names>A-M</given-names></name></person-group><article-title>The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis</article-title><source> European Journal of Emergency Medicine</source><year>2011</year><volume>18</volume><issue>3</issue><fpage>148</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">20926952</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whinnett</surname><given-names>ZI</given-names></name><name><surname>Sohaib</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>DW</given-names></name></person-group><article-title>Diagnosis and management of supraventricular tachycardia</article-title><source> BMJ</source><year>2012</year><volume>345</volume><fpage>e7769</fpage><pub-id pub-id-type="pmid">23233691</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname><given-names>MB</given-names></name><name><surname>Wald</surname><given-names>RW</given-names></name><name><surname>Sharma</surname><given-names>AD</given-names></name><name><surname>Huerta</surname><given-names>F</given-names></name><name><surname>Cameron</surname><given-names>DA</given-names></name></person-group><article-title>Vagal techniques for termination of paroxysmal supraventricular tachycardia</article-title><source> The American journal of cardiology</source><year>1980</year><volume>46</volume><issue>4</issue><fpage>655</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">7416025</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Z-C</given-names></name><name><surname>Chen</surname><given-names>S-A</given-names></name><name><surname>Tai</surname><given-names>C-T</given-names></name><name><surname>Chiang</surname><given-names>C-E</given-names></name><name><surname>Chiou</surname><given-names>C-W</given-names></name><name><surname>Chang</surname><given-names>M-S</given-names></name></person-group><article-title>Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia</article-title><source> Circulation</source><year>1998</year><volume>98</volume><issue>24</issue><fpage>2716</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">9851958</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Anantharaman</surname><given-names>V</given-names></name><name><surname>Teo</surname><given-names>W</given-names></name><name><surname>Goh</surname><given-names>P</given-names></name><name><surname>Tan</surname><given-names>A</given-names></name></person-group><article-title>Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage</article-title><source> Annals of emergency medicine</source><year>1998</year><volume>31</volume><issue>1</issue><fpage>30</fpage><lpage>5</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G</given-names></name></person-group><article-title>Management of supraventricular tachycardia using the Valsalva manoeuvre: a historical review and summary of published evidence</article-title><source> European Journal of Emergency Medicine</source><year>2012</year><volume>19</volume><issue>6</issue><fpage>346</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">22186147</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>JD</given-names></name><name><surname>DiMarco</surname><given-names>JP</given-names></name></person-group><article-title>Contemporary management of paroxysmal supraventricular tachycardia</article-title><source> Circulation</source><year>2003</year><volume>107</volume><issue>8</issue><fpage>1096</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12615783</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohinki</surname><given-names>D</given-names></name><name><surname>Obel</surname><given-names>OA</given-names></name></person-group><article-title>Current trends in supraventricular tachycardia management</article-title><source> The Ochsner Journal</source><year>2014</year><volume>14</volume><issue>4</issue><fpage>586</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">25598724</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>DM</given-names></name><name><surname>Auble</surname><given-names>TF</given-names></name><name><surname>Yealy</surname><given-names>DM</given-names></name></person-group><article-title>First-line management of paroxysmal supraventricular tachycardia</article-title><source> The American journal of emergency medicine</source><year>1999</year><volume>17</volume><issue>2</issue><fpage>214</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10102337</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Looga</surname><given-names>R</given-names></name></person-group><article-title>The Valsalva manoeuvre&#x02014;cardiovascular effects and performance technique: a critical review</article-title><source> Respiratory physiology &#x00026; neurobiology</source><year>2005</year><volume>147</volume><issue>1</issue><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">15848122</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname><given-names>MB</given-names></name><name><surname>Wald</surname><given-names>RW</given-names></name><name><surname>Finley</surname><given-names>JP</given-names></name><name><surname>Bonet</surname><given-names>JF</given-names></name><name><surname>Downar</surname><given-names>E</given-names></name><name><surname>Sharma</surname><given-names>AD</given-names></name></person-group><article-title>Valsalva termination of ventricular tachycardia</article-title><source> Circulation</source><year>1980</year><volume>62</volume><issue>4</issue><fpage>843</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">6773699</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>DM</given-names></name><name><surname>Wong</surname><given-names>LF</given-names></name></person-group><article-title>Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supra&#x02010;ventricular tachycardia is common</article-title><source> Emergency Medicine Australasia</source><year>2004</year><volume>16</volume><issue>4</issue><fpage>284</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15283715</pub-id></element-citation></ref></ref-list></back></article>